A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Clinical trial NCT07076407 · RECRUITING

Trial details

NCT number: NCT07076407
Sponsor: Xenon Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2025-07-08
Primary completion: 2027-05-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.